Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Non-Muscle Invasive Bladder Neoplasms × disitamab vedotin × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 6 Stomach Neoplasms 3 Urinary Bladder Neoplasms 2 Ovarian Neoplasms 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Neoplasms 1 Muscle Invasive Bladder Cancer (MIBC) 1 Head and Neck Neoplasms 1 HER2-low Breast Cancer 1 Endometrial Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Non-Small-Cell Lung 1 Biliary Tract Neoplasms 1 Advanced Breast Cancer 1

Interventions

Gemcitabine 17 Mitomycin 9 Docetaxel 6 erdafitinib 5 dodecyl maltoside 4 Cystoscopy 4 BCG Vaccine 4 durvalumab 2 Radiotherapy 2 ALT-803 2 5-aminolevulinic acid hexyl ester 2 viscum album peptide 1 toripalimab 1 pirarubicin 1 pemigatinib 1 monalizumab 1 hydroxycamptothecinum 1 enfortumab vedotin 1 bicalutamide 1 Urine Specimen Collection 1 Transurethral Resection of Bladder 1 Surveys and Questionnaires 1 Patient Discharge 1 Paclitaxel 1 Nonsteroidal Anti-Androgens 1 Mitozytrex 1 Maintenance 1 Magnetic Resonance Spectroscopy 1 Injections 1 Imiquimod 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡